Hepatitis B reactivation during combination chemotherapy for AIDS-related lymphoma is uncommon and does not adversely affect outcome
- Resource Type
- Source
- Blood. 103:2431-2432
- Subject
Anti-HIV Agents Immunology medicine.disease_cause Biochemistry AIDS-related lymphoma Recurrence Risk Factors medicine Humans Survival rate Lymphoma, AIDS-Related Hepatitis B virus business.industry virus diseases Cancer Combination chemotherapy Cell Biology Hematology Hepatitis B medicine.disease digestive system diseases Lymphoma Survival Rate Complication business - Language
- ISSN
- 1528-0020
0006-4971